CIK: 1429933 - Address: C/O Celldex Therapeutics, Inc., 53 Frontage Road, Suite 220, Hampton, NJ 08827
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret114214227-65
P%wins50755050752554

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/17/22 16:06
8/15/22
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarucci Anthony SNJDOP,CEOM.d6145.12012028D
8/17/22 16:06
8/15/22
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarucci Anthony SNJDOP,CEOS.d-4,52037.660-120-8128D
8/9/21 07:21
8/5/21
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarucci Anthony SNJDOP,CEOM.d14942.00041527D
6/10/20 07:54
6/9/20
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarucci Anthony SNJDOP,CEOP463.0601533819D
8/14/15 08:01
8/13/15
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarucci Anthony SNJDOP,CEOP9716.813361350D-199-19-36-32-32-29-23-1-18-6-10-56-73
8/10/11 09:54
8/9/11
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarucci Anthony SMADOP,CEOP362.411155D-60-47-25-32-27-23-26-11-87699576
9/13/10 10:24
9/10/10
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarucci Anthony SMAOP,CEOP413.453120D-68-37-33-32-32-21-191138272010-23
11/9/09 13:45
11/9/09
CLDXCelldex Therapeutics, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticMarucci Anthony SNJOP,CEOP515.102105D-16-14-40-23-1-120635-10-1260-4

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact